Chemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma

NCT00387959 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Lymphoma

Interventions

BIOLOGICAL: filgrastim
BIOLOGICAL: rituximab
DRUG: cyclophosphamide
DRUG: cyclosporine
DRUG: fludarabine phosphate
DRUG: mycophenolate mofetil
PROCEDURE: allogeneic hematopoietic stem cell transplantation
PROCEDURE: umbilical cord blood transplantation
RADIATION: total-body irradiation

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]